Brian J. Druker summits Mt. Hood in 1996The last time Brian J. Druker ran a marathon, his daughter, Julia, was six months old.
When I started this column, I was wanting to retain the sense of connection that I had to the greater cancer community as I stepped away into a period of disconnection.
With recent leaps in artificial intelligence, there is major potential to turn computing advances into gains for human health.
Alec C. Kimmelman was named CEO and dean of NYU Grossman School of Medicine.
Don S. Dizon will join Tufts Medicine in June 2025 as the system chief of hematology-oncology for the cancer service line. He will be proposed as the Jane F. Desforges endowed Professor in Hematology-Oncology at Tufts University School of Medicine.
Karen PollokTim LautenschlaegerJiang BianKaren Pollok was named associate director of basic science research and Tim Lautenschlaeger was named associate director of clinical research at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center. Jiang Bian also recently began as chief research information officer.
Cancer Research UK and partners on March 31 committed £5.5 million in funding to form a research team tasked with making personalized medicine a reality for people with colorectal cancer. The initiative is designed to unite research expertise and solve unanswered questions about the disease.
University Hospitals Cleveland Medical Center has announced a collaboration with global healthcare AI company Qure.ai to deploy chest X-ray AI supporting earlier identification of lung cancers.
The University of Texas MD Anderson Cancer Center on March 31 broke ground on a new 470,000-square-foot facility in Sugar Land, bringing a range of cancer services closer to those living in Southwest Houston and the surrounding areas.
Although lung cancer screening is recommended in the U.S. for certain individuals with a history of smoking, only 18% of eligible individuals in the U.S. get screened.
